Ivantis Hydrus Microstent Beats Glaukos iStent In Glaucoma Study

In the randomized COMPARE trial, eyes treated with Ivantis' Hydrus Microstent were about twice as likely to not need medication than eyes treated with two Glaukos iStent trabecular micro-bypass stents one year after implant  The one-year results of the trial have been accepted for publication in Opthalmology.